Acesion Pharma Stock

Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation.

Sign up today and learn more about Acesion Pharma Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Acesion Pharma Stock

Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation. The company's medical drugs develop treatments for atrial fibrillation which is the most common type of cardiac arrhythmia by following the concept of inhibiting a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm, providing consumers with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.

Funding History

January 2014$1.6M
December 2014$2.5M
January 2016$6.0M
November 2016$9.1M
September 2023$45.0M

Management

Chief Medical Officer and Head of Development

Anders Gaarsdal Holst

CFO

Torgeir Vaage

COO and Co-Founder

Ulrik Sørensen

Board Chairman

Bobby Soni

Member Board of Directors

Morten Graugaard Døssing

Medical Advisor

Nils Edvardsson

Vice President CMC

Breian Knudsen

CSO, Board member and Co-Founder

Morten Grunnet

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo